Vis enkel innførsel

dc.contributor.authorGreen, Samantha
dc.contributor.authorPerrott, Sarah L.
dc.contributor.authorMcCleary, Andrew
dc.contributor.authorSleeman, Isobel
dc.contributor.authorMaple-Grødem, Jodi
dc.contributor.authorCounsell, Carl E.
dc.contributor.authorMacleod, Angus D.
dc.date.accessioned2021-10-27T09:12:43Z
dc.date.available2021-10-27T09:12:43Z
dc.date.created2021-10-25T15:26:12Z
dc.date.issued2021-10
dc.identifier.citationGreen, S., Perrot, S.L., McCleary, A. et al. (2021) First delirium episode in Parkinson’s disease and parkinsonism: incidence, predictors, and outcomes. NPJ Parkinson's Disease, 7 (1), 92, 1-9.en_US
dc.identifier.issn2373-8057
dc.identifier.urihttps://hdl.handle.net/11250/2825916
dc.description.abstractTo define the incidence, predictors and prognosis of the first hospital delirium episode in Parkinson’s disease (PD) and atypical parkinsonism (AP), we identified the first hospital episode of delirium after diagnosis in the Parkinsonism Incidence in North-East Scotland (PINE) study, a prospective community-based incidence cohort of parkinsonism, using chart-based criteria to define delirium. Of 296 patients (189=PD, 107=AP [dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, vascular parkinsonism]), 152 developed delirium (PD = 98, AP = 54). Incidence of first hospital delirium episode per 100 person years was 8.1 (95% confidence interval [CI] 6.6–9.9) in PD and 18.5 (95% CI 13.9–24.7) in AP. Independent predictors of delirium were atypical parkinsonism (Hazard ratio [HR] vs PD = 2.83 [95% CI 1.60–5.03], age in PD but not in AP (HR for 10-year increase 2.29 [95% CI 1.74–3.02]), baseline MMSE (HR = 0.94 [95% CI 0.89–0.99]), APOE ε4 in PD (HR 2.16 [95% CI 1.15–4.08]), and MAPT H1/H1 in PD (HR 2.08 [95% CI 1.08–4.00]). Hazards of dementia and death after delirium vs before delirium were increased (dementia: HR = 6.93 [95% CI 4.18–11.48] in parkinsonism; death: HR = 3.76 [95% CI 2.65–5.35] in PD, 1.59 [95% CI 1.04–2.42] in AP). Delirium is a common non-motor feature of PD and AP and is associated with increased hazards of dementia and mortality. Whether interventions for early identification and treatment improve outcomes requires investigation.en_US
dc.language.isoengen_US
dc.publisherSpringer Nature Switzerland AGen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectParkinsonen_US
dc.subjectnevrologien_US
dc.titleFirst delirium episode in Parkinson’s disease and parkinsonism: incidence, predictors, and outcomesen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© The Author(s) 2021en_US
dc.subject.nsiVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Nevrologi: 752en_US
dc.source.pagenumber1-9en_US
dc.source.volume7en_US
dc.source.journalNPJ Parkinson's Diseaseen_US
dc.source.issue1en_US
dc.identifier.doi10.1038/s41531-021-00234-2
dc.identifier.cristin1948342
dc.source.articlenumber92 (2021)en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal